Makes a brain-responsive neuromodulation system for drug-resistant epilepsy.
Industry: Health Care
First Day Return: +46.8%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/24/2021 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 6.0 |
Deal Size ($mm) | $102 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 04/21/2021 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $102 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Mountain View, CA, United States |
Founded | 1997 |
Employees at IPO | 152 |
Website www.neuropace.com |